T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EARN
2476
Ellington Residential Mortgage REIT
EARN
$167M
| $227K | ﹤0.01% |
33,065
+10,110
| +44% | +$69.4K |
|
|
UHT
2477
Universal Health Realty Income Trust
UHT
$573M
| $227K | ﹤0.01% |
4,750
-2,393
| -34% | -$115K |
|
2478
Tootsie Roll Industries
TR
$3.02B
| $226K | ﹤0.01% |
5,970
-4,873
| -45% | -$178K |
|
|
CTIC
2479
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $226K | ﹤0.01% |
37,593
+1,654
| +5% | +$9.03K |
|
2480
ACM Research
ACMR
$5.65B
| $224K | ﹤0.01% |
29,100
+3,982
| +16% | +$33.7K |
|
2481
Customers Bancorp
CUBI
$2.82B
| $224K | ﹤0.01% |
7,890
+553
| +8% | +$17.2K |
|
2482
Daily Journal
DJCO
$828M
| $224K | ﹤0.01% |
895
+15
| +2% | +$4.06K |
|
2483
Omega Flex
OFLX
$291M
| $222K | ﹤0.01% |
+2,381
| New | +$225K |
|
2484
Pulmonx
LUNG
$92.8M
| $220K | ﹤0.01% |
26,104
+708
| +3% | +$6.73K |
|
2485
Hayward Holdings
HAYW
$3.24B
| $219K | ﹤0.01% |
23,298
+36
| +0.2% | +$335 |
|
|
CONN
2486
DELISTED
Conn's Inc.
CONN
| $219K | ﹤0.01% |
31,843
+487
| +2% | +$3.85K |
|
2487
Groupon
GRPN
$894M
| $217K | ﹤0.01% |
25,335
+1,800
| +8% | +$13.9K |
|
2488
Ribbon Communications
RBBN
$377M
| $216K | ﹤0.01% |
77,380
+15,900
| +26% | +$41.2K |
|
2489
Veru
VERU
$46M
| $216K | ﹤0.01% |
4,086
+133
| +3% | +$11K |
|
2490
Axogen
AXGN
$2.58B
| $215K | ﹤0.01% |
21,585
+830
| +4% | +$9.22K |
|
2491
Designer Brands
DBI
$312M
| $214K | ﹤0.01% |
21,887
+5,316
| +32% | +$71.7K |
|
2492
DHT Holdings
DHT
$3.09B
| $214K | ﹤0.01% |
24,048
+2,012
| +9% | +$18.3K |
|
2493
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $213K | ﹤0.01% |
+6,596
| New | +$206K |
|
|
ONT
2494
Onterris Inc
ONT
$615M
| $213K | ﹤0.01% |
+4,809
| New | +$203K |
|
2495
Ocugen
OCGN
$458M
| $213K | ﹤0.01% |
163,732
+26,910
| +20% | +$41.9K |
|
|
OLO
2496
DELISTED
Olo Inc
OLO
| $213K | ﹤0.01% |
34,101
-123,452
| -78% | -$932K |
|
2497
Sotera Health
SHC
$5.43B
| $213K | ﹤0.01% |
25,598
+4,614
| +22% | +$34.4K |
|
2498
Willis Lease Finance
WLFC
$1.15B
| $212K | ﹤0.01% |
+10,800
| New | +$162K |
|
2499
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $212K | ﹤0.01% |
3,400
| – | – |
|
2500
Grid Dynamics Holdings
GDYN
$644M
| $211K | ﹤0.01% |
18,848
+3,635
| +24% | +$47.1K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.